Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
39.77
+0.09 (0.23%)
At close: Mar 9, 2026, 4:00 PM EDT
40.00
+0.23 (0.58%)
After-hours: Mar 9, 2026, 7:24 PM EDT

Soleno Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
20.89-175.85-38.99-24.07-30.91
Upgrade
Depreciation & Amortization
2.021.991.961.961.96
Upgrade
Other Amortization
0.04----
Upgrade
Loss (Gain) From Sale of Investments
-3.52-4.9---
Upgrade
Stock-Based Compensation
45.8599.965.952.533.28
Upgrade
Other Operating Activities
6.163.693.22-0.45-0.95
Upgrade
Change in Accounts Receivable
-28.21----
Upgrade
Change in Inventory
-14.03----
Upgrade
Change in Accounts Payable
3.615.671.37-1.48-0.24
Upgrade
Change in Other Net Operating Assets
13.990.351.560.72-0.91
Upgrade
Operating Cash Flow
46.8-69.1-24.94-20.78-27.77
Upgrade
Capital Expenditures
-0.07-0.22--0.01-0.02
Upgrade
Investment in Securities
-201.71-225.46---
Upgrade
Investing Cash Flow
-201.78-225.68--0.01-0.02
Upgrade
Long-Term Debt Issued
-49.89---
Upgrade
Long-Term Debt Repaid
-----0.01
Upgrade
Total Debt Repaid
-----0.01
Upgrade
Net Debt Issued (Repaid)
-49.89---0.01
Upgrade
Issuance of Common Stock
238.11163.14180.0214.11-
Upgrade
Repurchase of Common Stock
-100.89---0.02-0.12
Upgrade
Other Financing Activities
-0.06----
Upgrade
Financing Cash Flow
137.16213.03180.0214.09-0.13
Upgrade
Net Cash Flow
-17.82-81.75155.08-6.7-27.92
Upgrade
Free Cash Flow
46.73-69.31-24.94-20.79-27.79
Upgrade
Free Cash Flow Margin
24.54%----
Upgrade
Free Cash Flow Per Share
0.89-1.73-1.51-2.48-5.23
Upgrade
Cash Interest Paid
4.530.21---
Upgrade
Levered Free Cash Flow
48.27-7.47-12.82-11.71-15.79
Upgrade
Unlevered Free Cash Flow
51.66-7.33-12.82-11.71-15.79
Upgrade
Change in Working Capital
-24.636.022.93-0.76-1.15
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.